Medicamen Biotech Share Price
28 Sep, 2026 3:56 PM (IST)
Medicamen Biotech Performance
- Today's Low
- ₹313
- Today's High
- ₹330
- 52 Week Low
- ₹212
- 52 Week High
- ₹448
- Open Price₹315
- Previous Close₹315
- Volume41,948
- 50 DMA₹278.40
- 100 DMA₹271.90
- 200 DMA₹290.60
Medicamen Biotech Chart
Investment Returns
- Over 1 Month + 41.7%
- Over 3 Month + 43.27%
- Over 6 Month + 36.91%
- Over 1 Year + 7.71%
Smart Investing Starts Here Start SIP with Medicamen Biotech for Steady Growth!
Medicamen Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 41
- PEG Ratio
- 1.9
- Market Cap Cr
- 444
- P/B Ratio
- 1.6
- Average True Range
- 21.3
- EPS
- 8
- Dividend Yield
- 0.3
- MACD Signal
- 18.3
- RSI
- 63.46
- MFI
- 91.55
Latest Stock News Updates
Voting Results of 33rd Annual General Meeting - September 26, 2026
- BSE India
- 12 hours 43 minutes ago
Closure of Trading Window- Septemeber 30, 2026
- BSE India
- 15 hours 25 minutes ago
Outcome of 33rd Annaul general Meeting held on Saturday, September 26, 2026 at 12.00 Noon.
- BSE India
- 2 days 12 hours ago
Medicamen Biotech Financials
Medicamen Biotech Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹303.50
- 50 Day
- ₹278.40
- 100 Day
- ₹271.90
- 200 Day
- ₹290.60
Resistance and Support
- R3 351.10
- R2 340.70
- R1 333.80
- S1 316.50
- S2 306.10
- S3 299.20
Medicamen Biotech Corporate Actions - Bonus, Splits, Dividends
About Medicamen Biotech
Medicamen Biotech engaged in the research, development and manufacturing, and global marketing of Finished Dosage Forms (FDFs) and liquid formulations. MBL specializes in Oncology, Cardiovascular Diseases (CVD), Central Nervous System (CNS), Diabetology, Anti-Malarials, Antibiotics and Pain Managemen with an established presence across more than 35 countries in the Rest of the World (ROW) and an expanding footprint in highly regulated markets, View More- NSE Symbol
- MEDICAMEQ
- BSE Symbol
- 531146
- ISIN
- INE646B01010
Similar Stocks to Medicamen Biotech
Popular Stocks
Medicamen Biotech FAQs
Medicamen Biotech share price is ₹326 As on 29 September, 2026 | 03:27
The Market Cap of Medicamen Biotech is ₹443.5 Cr As on 29 September, 2026 | 03:27
The P/E ratio of Medicamen Biotech is 41 As on 29 September, 2026 | 03:27
The PB ratio of Medicamen Biotech is 1.6 As on 29 September, 2026 | 03:27
The 52 week High & Low of Medicamen Biotech is ₹447.6/₹212.4 respectively As on 29 September, 2026 | 03:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.